Skip to main navigation Skip to search Skip to main content

Trial 2138IL/0012

  • Hobbs, Richard (Principal Investigator)

Project Details

Short titleTrial 2138IL/0012
StatusFinished
Effective start/end date15/08/93 → 30/09/94

Funding

  • AstraZeneca, United Kingdom